Antiangiogenic drugs as a novel anticancer therapeutic strategy which are the more promising agents? What are the clinical developments and indications?

Giampietro Gasparini

doi:10.1016/S1040-8428(97)10001-4

Antiangiogenic drugs as a novel anticancer therapeutic strategy which are the more promising agents? What are the clinical developments and indications?

Giampietro Gasparini

IRCCS Giovanni Paolo II

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	147-162
Number of pages	16
Journal	Critical Reviews in Oncology/Hematology
Volume	26
Issue number	3
DOIs	https://doi.org/10.1016/S1040-8428(97)10001-4
Publication status	Published - Dec 1997

ASJC Scopus subject areas

Cancer Research
Hematology
Oncology

Access to Document

10.1016/S1040-8428(97)10001-4

Cite this

@article{2d9492098a2348c5b01cd3551ef04630,

title = "Antiangiogenic drugs as a novel anticancer therapeutic strategy which are the more promising agents? What are the clinical developments and indications?",

author = "Giampietro Gasparini",

year = "1997",

month = dec,

doi = "10.1016/S1040-8428(97)10001-4",

language = "English",

volume = "26",

pages = "147--162",

journal = "Critical Reviews in Oncology/Hematology",

issn = "1040-8428",